Hepatitis C treatment uptake among people who inject drugs in the oral direct‐acting antiviral era-Reference-Cited by-同舟云学术

Hepatitis C treatment uptake among people who inject drugs in the oral direct‐acting antiviral era

Published:2020-09-23 Issue:10 Volume:40 Page:2407-2416
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Falade‐Nwulia Oluwaseun¹^ORCID,Gicquelais Rachel E.²,Astemborski Jacquie²,McCormick Sean D.¹^ORCID,Kirk Greg²,Sulkowski Mark¹,Thomas David L.¹,Mehta Shruti H.²

Affiliation:

1. Johns Hopkins University School of Medicine Baltimore MD USA

2. Johns Hopkins University Bloomberg School of Public Health Baltimore MD USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14634

Reference62 articles.

1. Direct-acting antiviral sustained virologic response: Impact on mortality in patients without advanced liver disease

2. Hepatitis C Virus–Infected Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment With Interferon-Free Regimens

3. Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

4. Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection

5. Efficacy of Direct-acting Antivirals for Chronic Hepatitis C Virus Infection in People Who Inject Drugs or Receive Opioid Substitution Therapy: A Systematic Review and Meta-analysis

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peer-Assisted Telemedicine for Hepatitis C (PATHS): Process evaluation results from a State Opioid Response-funded program;Journal of Substance Use and Addiction Treatment;2024-12

2. Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and cure;Drug and Alcohol Dependence;2024-09

3. A COMPARISON OF SOFOSBUVIR/VELPATASVIR (S/V) AND GLECAPREVIR/PIBRENTASVIR (G/P) FOR THE TREATMENT OF HCV INFECTION AMONG HCV-INFECTED PEOPLE WHO USE DRUGS (PWUD);Journal of Virus Eradication;2024-08

4. How to better improve the treatment and outcomes of HCV in psychiatric patients: review of a Belgian monocentric psychiatric center;Acta Gastro Enterologica Belgica;2024-06

5. Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial;Viruses;2024-05-27